- Home
- IBO
as 01-17-2025 4:00pm EST
Stocks
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | HOUSTON |
| Market Cap: | 17.9M | IPO Year: | 2024 |
| Target Price: | N/A | AVG Volume (30 days): | 31.8K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.01 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.16 - $3.25 | Next Earning Date: | 02-23-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest IMPACT BIOMEDICAL INC News
IBO Breaking Stock News: Dive into IBO Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 months ago
Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision
GlobeNewswire
3 months ago
Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease
GlobeNewswire
3 months ago
Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates
GlobeNewswire
4 months ago
Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue
GlobeNewswire
4 months ago
Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth
Compare IBO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IBO IMPACT BIOMEDICAL INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.